SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-18-037040
Filing Date
2018-05-31
Accepted
2018-05-31 11:15:35
Documents
1
Group Members
INDUSTRY VENTURES MANAGEMENT VIII, LLCJOHAN D. SWILDENS

Document Format Files

Seq Description Document Type Size
1 SC 13G a18-14532_1sc13g.htm SC 13G 126754
  Complete submission text file 0001104659-18-037040.txt   128317
Mailing Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063
Business Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063 650-216-3500
ACELRX PHARMACEUTICALS INC (Subject) CIK: 0001427925 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-86112 | Film No.: 18870489
SIC: 2834 Pharmaceutical Preparations

Mailing Address 30 HOTALING PLACE, 3RD FLOOR SAN FRANCISCO CA 94111
Business Address 30 HOTALING PLACE, 3RD FLOOR SAN FRANCISCO CA 94111 415-273-4201
Industry Ventures Secondary VIII, L.P. (Filed by) CIK: 0001665487 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G